Priya Abani

speaker

352 appearances 1 recordings 1 series first heard Feb 2026 last heard 12 Feb

Priya Abani’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Feb 2026 with 1.

Appearances

newest first · ▶ plays the moment

Vanguards of Healthcare by Bloomberg Intelligence · AliveCor’s Priya Abani Uses Amazon Experience to Democratize ECG Tech · 12 Feb 2026 podcast

And that's where we basically, as I mentioned with the 12 lead,

The really differentiator for us is our AI intelligence.

So we are going definitely about very specific cardiac conditions.

And we are providing a level of detail in a device that is, again, smaller, easier to use, comparable to like a $15,000 device.

And the whole thing is like you don't want the data just to sit on somebody's phone, right?

You want the data to flow in the physician's workflow.

So there's a lot of work that needs to happen in bridging this gap between a consumer-friendly device

and like a high fidelity clinical tool.

And then there is the reimbursement workflow.

So now think of it, right?

A company like ours that has been so focused on medical diagnostics, we are still trying to figure out this whole workflow thing.

And now you suddenly have like, you know, eight different types of wellness devices, which is collecting a lot of other information

a lot of it is really good information but again not something specific that a patient can do something with it how does that flow into the system and what is a high fidelity piece of data and what is not all of that is yet to be determined but

Let me go back to your question about the FDA, right?

So I think the policies that they are making are very promising for the industry.

What we like to do is we I think it's critical that we distinguish between wellness data and clinically valid metrics.

And this helps, again, ensure actionable outcomes.

and prevent clinicians from being overburdened by digital noise.

So as more and more wellness technology and data fall under enforcement discretion, I think the risk remains that the noise could overwhelm clinical workflows.

And I think that's where to truly benefit patients and clinicians, it is critical that only clinically valid medical grade technology is used to inform like EHRs and clinical decisions.

Showing 261–280 of 352 · page 14 of 18